Picture of Sartorius Stedim Biotech SA logo

DIM — Sartorius Stedim Biotech SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Sartorius Stedim Biotech Says Q1 Revenue At EUR 762 Mln

April 23 (Reuters) - Sartorius Stedim Biotech SA STDM.PA:

SARTORIUS STEDIM BIOTECH REPORTS ROBUST FIRST-QUARTER RESULTS FOR FISCAL 2026

Q1 SALES REVENUE AT 762 MILLION EUROS, UP 7.9% IN CONSTANT CURRENCIES

Q1 UNDERLYING EBITDA AT 233 MILLION EUROS, MARGIN 30.7%, NET PROFIT 88 MILLION EUROS

MANAGEMENT CONFIRMS FULL-YEAR GUIDANCE FOR FISCAL 2026

Source text: ID:nEQbBxw6Ca

Further company coverage: STDM.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Sartorius Stedim Biotech SA

See all news